PTGS2 and myocardial infarction: Treatment with the nonsteroidal anti-inflammatory drug was proposed, but the clinical study showed that only high dose of aspirin (900 mg/day) could minimize the development of the early stage of DR [54], while systemic COX-2 inhibitor increased the risk of heart attacks and strokes in DR patients [55].